Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct:160:105053.
doi: 10.1016/j.phrs.2020.105053. Epub 2020 Jun 30.

Mortality in COVID-19 patients treated with ACEIs/ARBs: Re-estimated meta-analysis results following the Mehra et al. retraction

Affiliations
Comment

Mortality in COVID-19 patients treated with ACEIs/ARBs: Re-estimated meta-analysis results following the Mehra et al. retraction

Ahmad Alamer et al. Pharmacol Res. 2020 Oct.

Retraction in

  • 10.1016/j.phrs.2020.105053
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Forest plot of re-estimated ACEI/ARB exposure and risk of mortality in (A) Covid-19 patients and (B) Covid-19 patients with antihypertensive indication.

Comment on

References

    1. Mehra M.R., Desai S.S., Kuy S., Henry T.D., Patel A.N. Cardiovascular disease, drug therapy, and mortality in Covid-19. N. Engl. J. Med. 2020;382:e102. - PMC - PubMed
    1. Mehra M.R., Desai S.S., Kuy S., Henry T.D., Patel A.N. Retraction: cardiovascular disease, drug therapy, and mortality in Covid-19. N. Engl. J. Med. 2020;382:2582. doi: 10.1056/NEJMoa2007621. N Engl J Med. - DOI - PMC - PubMed
    1. Mehra M.R., Desai S.S., Ruschitzka F., Patel A.N. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020 doi: 10.1016/S0140-6736(20)31180-6. published online May 22. - DOI - PMC - PubMed
    1. Mehra M.R., Ruschitzka F., Patel A.N. Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020;395 1820 6. Epub 2020 Jun 5. - PMC - PubMed
    1. Zhang X., Yu J., Pan L.Y., Jiang H.Y. ACEI/ARB use and risk of infection or severity or mortality of COVID-19: a systematic review and meta-analysis. Pharmacol. Res. 2020;158:104927. - PMC - PubMed